A — Agilent Technologies Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual cashflow statement for Agilent Technologies, fiscal year end - October 31st, USD millions except per share, conversion factor applied.

	2019 October 31st	2020 October 31st	2021 October 31st	2022 October 31st	2023 October 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	1,071	719	1,210	1,254	1,240
Depreciation
Deferred Taxes
Non-Cash Items	106	190	42	211	433
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-139	-325	-102	-478	-116
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Net Change in Other Assets & Liabilities
Cash from Operating Activities	1,021	921	1,485	1,312	1,772
Capital Expenditures	-156	-119	-189	-291	-298
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-1,434	-28	-560	-47	-12
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Other Investing Cash Flow
Cash from Investing Activities	-1,590	-147	-749	-338	-310
Financing Cash Flow Items	-24	-41	-83	-67	-122
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-299	-717	-696	-1,372	-930
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-866	59	43	-434	537